Currently, several drugs are being tried to relive the symptoms of COVID-19 including dapagliflozin (SGLT2-antidiabetic) lopinavir/ritonavir, darunavir/umifenovir (anti-HIV), remdesivir (anti-Ebola), favipiravir and dipyridamole (anti-hypertensive) [41,58,59,60,61,62,63]. This evidence concerns the gene SLC5A2 and COVID-19.